NephroGenex, Inc. Operating Income
NephroGenex, Inc. reported Operating Income of -$22.32 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2016-03-29
- NephroGenex, Inc. operating income (loss) for the quarter ending 2015-12-31 was -$5.83M.
- NephroGenex, Inc. operating income (loss) for the quarter ending 2015-09-30 was -$5.21M.
- NephroGenex, Inc. operating income (loss) for the quarter ending 2015-06-30 was -$6.24M.
- NephroGenex, Inc. operating income (loss) for the quarter ending 2015-03-31 was -$5.04M.
- NephroGenex, Inc. operating income (loss) for fiscal 2015 was -$22.32M.
- NephroGenex, Inc. operating income (loss) for fiscal 2014 was -$16.59M.
- NephroGenex, Inc. operating income (loss) for fiscal 2013 was -$2.51M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 118 month |
|---|---|---|---|---|---|---|
| 2015-12-31 | -$5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$11.04M derived: sum of 2 quarters · filed 2016-03-29 | -$17.28M derived: sum of 3 quarters · filed 2016-03-29 | -$22.32M 10-K · filed 2016-03-29 | ||
| 2015-09-30 | -$5.21M 10-Q · filed 2015-11-12 | -$11.45M derived: sum of 2 quarters · filed 2015-11-12 | -$16.49M 10-Q · filed 2015-11-12 | -$21.72M derived: sum of 4 quarters · filed 2016-03-29 | ||
| 2015-06-30 | -$6.24M 10-Q · filed 2015-08-12 | -$11.28M 10-Q · filed 2015-08-12 | -$16.51M derived: sum of 3 quarters · filed 2016-03-29 | -$20.94M derived: sum of 4 quarters · filed 2016-03-29 | ||
| 2015-03-31 | -$5.04M 10-Q · filed 2015-05-13 | -$10.27M derived: sum of 2 quarters · filed 2016-03-29 | -$14.70M derived: sum of 3 quarters · filed 2016-03-29 | -$20.13M derived: sum of 4 quarters · filed 2016-03-29 | ||
| 2014-12-31 | -$5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$9.66M derived: sum of 2 quarters · filed 2016-03-29 | -$15.10M derived: sum of 3 quarters · filed 2016-03-29 | -$16.59M 10-K · filed 2016-03-29 | ||
| 2014-09-30 | -$4.43M 10-Q · filed 2015-11-12 | -$9.86M derived: sum of 2 quarters · filed 2015-11-12 | -$11.35M 10-Q · filed 2015-11-12 | -$12.40M derived: sum of 4 quarters · filed 2015-11-12 | ||
| 2014-06-30 | -$5.43M 10-Q · filed 2015-08-12 | -$6.93M 10-Q · filed 2015-08-12 | -$7.98M derived: sum of 3 quarters · filed 2015-08-12 | -$8.65M derived: sum of 4 quarters · filed 2015-08-12 | ||
| 2014-03-31 | -$1.49M 10-Q · filed 2015-05-13 | -$1.49M 10-Q · filed 2014-05-14 | -$2.54M derived: sum of 2 quarters · filed 2015-05-13 | -$3.22M derived: sum of 3 quarters · filed 2015-05-13 | -$3.60M derived: sum of 4 quarters · filed 2015-05-13 | -$34.95M 10-Q · filed 2014-05-14 |
| 2013-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | -$1.73M derived: sum of 2 quarters · filed 2015-03-24 | -$2.10M derived: sum of 3 quarters · filed 2015-03-24 | -$2.51M 10-K · filed 2015-03-24 | ||
| 2013-09-30 | -$679.00K 10-Q · filed 2014-11-12 | -$1.05M derived: sum of 2 quarters · filed 2014-11-12 | -$1.46M 10-Q · filed 2014-11-12 | |||
| 2013-06-30 | -$375.00K 10-Q · filed 2014-08-12 | -$777.00K 10-Q · filed 2014-08-12 | ||||
| 2013-03-31 | -$402.70K 10-Q · filed 2014-05-14 |